Gland Pharma Limited (GLAND) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Gland Pharma Limited stock ₹4,931, price ₹3,334, upside +47.9%, quality 66 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Gland Pharma Limited
GLAND · NSECheap (32% below fair value), solid company and rising price: meets all 3 rules.
Main risks:
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range ₹869.74 – ₹4,201 · fair‑value band ₹3,276 – ₹6,371 · the ₹3,334 price screens below the ₹4,931 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Gland Pharma is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.
Show moreShow less
It engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules.
The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastro-intestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain/analgesics, respiratory and pulmonology, and vitamins, minerals, and nutrients.
In addition, it provides contract development, dossier compilation, technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Stock analysis
Gland Pharma Limited (GLAND) currently trades at ₹3,334, while our model-based Fair Value estimate is ₹4,931, implying the stock looks roughly 32% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹1,517 per share, and 0 of the 26 models we run sit above the ₹3,334 price.
Bear case: the Economic Profit group reads lowest at ₹595.79, and 26 of the 26 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹3,276 (bear) to ₹6,371 (bull), the price of ₹3,334 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 66/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Gland Pharma Limited reported revenue of ₹64.3B in FY2026 versus ₹44.0B in FY2022, a compound +9.9%/yr. Reported net income was ₹10.3B in FY2026, compounding −4.0%/yr from FY2022.
Key figures
Market cap ₹550B (≈ $5.8B) Mid · P/E ratio 44.5 · P/S ratio 8.18 · EPS (TTM) ₹74.95 · Dividend yield 0.6% · Net margin 16.8% · Return on equity 10.5% · Return on assets (EBIT) 15.1% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 56 out of 100 (medium confidence).
What moves the price
The share trades at its 52-week high and 110% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 48%, GLAND screens cheaper than that median.
Fair Value models
All 26 models by family
The fair value above starts from this blend and is adjusted for a year distorted by one-off effects.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch GLAND, get fair value alerts →
Earlier news
- Did Gland Pharma's 77% Run Pass You By? What Bulls Still Need
- India's Gland Pharma posts higher quarterly profit on Cenexi boost
- India's Gland Pharma posts quarterly profit rise on Cenexi recovery, Europe sales growth
Compare Gland Pharma Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 603 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs GLAND |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.07 | ¥53.04 | +10% | vs GLAND |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,880 | ₹1,983 | +5% | vs GLAND |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs GLAND |
| Merck KGaA MRK | €149.60 | €108.83 | −27% | vs GLAND |
| Galderma Group GALD | CHF 191.40 | CHF 112.30 | −41% | vs GLAND |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs GLAND |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs GLAND |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs GLAND |
| Divi's Laboratories Limited DIVISLAB | ₹11,442 | ₹1,567 | −86% | vs GLAND |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Gland Pharma Limited (GLAND) overvalued or undervalued?
What is the fair value of GLAND?
What is the quality score of GLAND?
What is the price target for Gland Pharma Limited (GLAND)?
What is the Gland Pharma Limited stock forecast for 2026?
What is the revenue of Gland Pharma Limited (GLAND)?
Does Gland Pharma Limited pay a dividend?
How much is the dividend of Gland Pharma Limited (GLAND) and when is the ex-dividend date?
What growth is priced into Gland Pharma Limited (GLAND)?
What discount rate (WACC) does the fair value of GLAND use?
What is a reverse DCF?
How much growth has Gland Pharma Limited (GLAND) delivered so far?
How fast is the sector of Gland Pharma Limited (GLAND) growing?
What is the free cash flow yield of Gland Pharma Limited (GLAND)?
What is the intrinsic value of Gland Pharma Limited (GLAND)?
Is Gland Pharma Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of GLAND?
How much is Gland Pharma Limited worth?
What do the bullish and bearish scenarios say about GLAND?
What is the P/E ratio of GLAND?
How solid is the balance sheet of Gland Pharma Limited (GLAND)?
How far is GLAND from its 52-week high?
Which stocks are comparable to Gland Pharma Limited?
Is Gland Pharma Limited stock attractive at the current price?
How is the fair value of GLAND calculated?
Is it still worth investing in stocks now?
What is the share price of Gland Pharma Limited (GLAND)?
What should I pay attention to with Gland Pharma Limited right now?
Key figures of Gland Pharma Limited
How large is the market capitalisation of Gland Pharma Limited (GLAND)?
What is the P/S ratio of Gland Pharma Limited (GLAND)?
What are the earnings per share of Gland Pharma Limited (GLAND)?
What is the dividend yield of Gland Pharma Limited (GLAND)?
What is the net margin of Gland Pharma Limited (GLAND)?
What is the return on equity of Gland Pharma Limited (GLAND)?
What is the EBIT return on assets of Gland Pharma Limited (GLAND)?
What is the operating margin of Gland Pharma Limited (GLAND)?
How fast is revenue growing at Gland Pharma Limited (GLAND)?
How fast are earnings growing at Gland Pharma Limited (GLAND)?
How much net cash does Gland Pharma Limited (GLAND) hold?
Watch Gland Pharma Limited in the live analysis
One click puts Gland Pharma Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.